About: Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $31.97 (+1.65%)
ARQT NASDAQ Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics Inc share price
Atividade de preço de ARQT
Último preço
$ 31,970
Variação (24h)
0,52 USD (1,65%)
Volume
1.75M
Volume (média 4 sem.)
-
Abertura
$ 31,40
Variação do dia
$ 31,15 - $ 32,08
Fechamento anterior
$ 31,45
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ARQT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals